Nicassist Translucent (Nicotine)

Nicotine, the active ingredient in Nicassist Translucent, is a nicotinic receptor agonist presented as a transdermal patch for transdermal use. It treats nicotine dependence and aids smoking cessation in adults.

GNH USA supplies Nicassist Translucent as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicotine delivered via Nicassist Translucent is used in the management of nicotine dependence and smoking cessation.

- Smoking cessation: reduces withdrawal symptoms and cravings, supporting quit attempts. - Tobacco use disorder: provides controlled nicotine delivery to facilitate gradual reduction. - Relapse prevention: maintains low nicotine levels to help prevent return to smoking.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild burning. - Sleep disturbance: difficulty falling asleep or staying asleep. - Vivid dreams or abnormal dreaming patterns. - Nausea or mild gastrointestinal upset. - Headache or light‑headedness.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives. - Severe skin rash or blistering. - Hypotension or marked drop in blood pressure. - Tachycardia or irregular heart rhythm. - Chest pain or angina. - Dizziness leading to falls.

Before using Nicassist Translucent, consider the following precautions.

- Assess cardiovascular status: nicotine may increase heart rate and blood pressure. - Avoid use in recent myocardial infarction: nicotine can exacerbate cardiac conditions. - Do not use in uncontrolled hypertension: monitor blood pressure regularly. - Pregnancy and breastfeeding: safety not established; use only if benefits outweigh risks. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicassist Translucent may interact with other medicines. Review the following.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis. - Beta‑blockers: nicotine may reduce their effectiveness. - Insulin or oral hypoglycemics: nicotine can affect glucose control.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs): may increase insomnia or jitteriness. - Caffeine: nicotine may enhance stimulant effects, leading to nervousness. - Antihypertensive agents: monitor blood pressure for additive effects.